Park Medi World Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Park Medi World Ltd is ₹ 220.25 as of 30 Oct 15:30 . The P/E Ratio of Park Medi World Ltd changed from 31.7 on March 2026 to 31.7 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of Park Medi World Ltd changed from ₹ 8191 crore on March 2026 to ₹ 8191 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of Park Medi World Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 483.36 crore. This represent the decline of -100% The revenue of Syngene International Ltd for the Sep '26 is ₹ 860.7 crore as compare to the Jun '26 revenue of ₹ 761.3 crore. This represent the growth of 13.06% The ebitda of Park Medi World Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 133.73 crore. This represent the decline of -100% The ebitda of Syngene International Ltd for the Sep '26 is ₹ 168.7 crore as compare to the Jun '26 ebitda of ₹ 102.6 crore. This represent the growth of 64.42% The net profit of Park Medi World Ltd changed from ₹ 45.65 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ 32.2 crore over 10 quarters. This represents a CAGR of -28.96% The Dividend Payout of Park Medi World Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About Park Medi World Ltd

Park Medi World Quarterly Result Overview Park Medi World quarterly results present a clear summary of financial performance across different reporting periods.
Investors can review revenue, profit, and overall business trends without studying detailed financial statements. Park Medi World quarterly results date helps track when each financial update is released during the year.
The overview shows how the company performs under changing business conditions and the market environment. Key Metrics of Park Medi World Quarterly Result Here are the main metrics typically covered: 1.
Revenue Revenue shows the total income generated from business activities during the reporting period.
Performance changes in quarterly results, such as Park Medi World Q3 results, may reflect seasonal demand and business cycles. 2.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of Park Medi World Ltd and Syngene International Ltd

Which company has a larger market capitalization, Park Medi World Ltd or Syngene International Ltd?

Market cap of Park Medi World Ltd is 9,513 Cr while Market cap of Syngene International Ltd is 16,251 Cr

What are the key factors driving the stock performance of Park Medi World Ltd and Syngene International Ltd?

The stock performance of Park Medi World Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Park Medi World Ltd and Syngene International Ltd?

As of November 1, 2026, the Park Medi World Ltd stock price is INR ₹220.25. On the other hand, Syngene International Ltd stock price is INR ₹402.6.

How do dividend payouts of Park Medi World Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Park Medi World Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.